Prediction of Development and Rupture Risk for Intracranial Unruptured Aneurysms
1 other identifier
observational
500
1 country
1
Brief Summary
In recent years, researches on the natural history and risk factors of intracranial unruptured aneurysms have become a hot topic at home and abroad. However, risk factors for aneurysm rupture is still unclear yet. The investigators' preliminary study focused on constructing a rupture risk prediction system for intracranial unruptured aneurysm in the investigators' single center. The investigators' result showed that three significant factors (sex, abnormal serum tumor necrosis factor (TNF)-α and coincidence of thin-walled regions (TWR) and normalized wall shear stress (NWSS)) stood out by using logistic regression to explore the rupture risk factors of intracranial unruptured aneurysms, which could help guide the clinical treatment of intracranial unruptured aneurysms. This study is to evaluate and improve the rupture predict model of intracranial unruptured aneurysm in multi-neurosurgical centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
October 13, 2022
October 1, 2022
5 years
October 10, 2022
October 11, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Predictive value of coincidence of TWR and NWSS for unruptured aneurysm rupture
at 5 years, the value of the factor (coincidence of TWR and NWSS) to predict aneurysm rupture risk will be analyzed
at 5 year
Predictive value of serum TNF-α for unruptured aneurysm rupture
at 5 years, the value of the factor (serum TNF-α) to predict aneurysm rupture risk will be analyzed
at 5 year
Predictive value of sex for unruptured aneurysm rupture
at 5 years, the value of the factor (sex) to predict aneurysm rupture risk will be analyzed
at 5 year
Secondary Outcomes (3)
Predictive value of coincidence of TWR and NWSS for unruptured aneurysm growth
at 5 year
Predictive value of serum TNF-α for unruptured aneurysm growth
at 5 year
Predictive value of sex for unruptured aneurysm growth
at 5 year
Study Arms (1)
Unruptured Intracranial Aneurysm
Interventions
Extensive clinical, biological and imaging data of unruptured intracranial aneurysm patients will be recorded during a 5 years follow-up.
Eligibility Criteria
The enrolled patients are who have unruptured asymptomatic aneurysm with a clinical, a biological and an imaging follow-up, without any relative treatment.
You may qualify if:
- Diagnosis of aneurysm by digital subtraction angiography (DSA);
- Age between 18-70 years old;
- Informed consent form for this study was signed
You may not qualify if:
- Dissecting aneurysms and saccular aneurysms with other vascular diseases such as arteriovenous malformations, moyamoya disease, and arteriovenous fistulas were excluded;
- Combined with serious systemic diseases;
- Patients who cannot receive MRI/magnetic resonance angiography (MRA) examinations due to severely impaired renal function, allergy, space claustrophobia or internal implants in the body.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitylead
- Jinhua Central Hospitalcollaborator
- Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical Universitycollaborator
- First Affiliated Hospital of Wenzhou Medical Universitycollaborator
- The Central Hospital of Lishui Citycollaborator
- Ningbo Medical Center Lihuili Hospitalcollaborator
Study Sites (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310029, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2022
First Posted
October 12, 2022
Study Start
January 1, 2023
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
October 13, 2022
Record last verified: 2022-10